🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Status
Completed
Location
PRA Health Sciences - Early Development Services
Start Date
2016-11-16
Trial ID
NCT02454712
Treatments Being Tested
The study is designed to test whether or not the rate and extent of absorpt...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-09
Trial ID
NCT01677039
The primary objective of the study is to determine the analgesic efficacy a...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2012-06
Trial ID
NCT01571362
The main purpose of this study is to determine if oxycodone and naltrexone ...
Status
Completed
Location
INC Research Toronto Inc.
Start Date
2013-02
Trial ID
NCT01775189
To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02089295
A single dose dose study to assess the pharmacokinetics (PK) of oxycodone, ...
Status
Recruiting
Location
Quotient Sciences
Start Date
2024-11-24
Trial ID
NCT06500793
Treatments Being Tested
To characterize the single- and multiple-dose pharmacokinetics of oxycodone...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-03
Trial ID
NCT01557257
Treatments Being Tested
This is a single-center, randomized, 7-way crossover, double-blind, active ...
Status
Completed
Location
Behavioral Pharmacology Research Unit
Start Date
2007-08
Trial ID
NCT00734461
Treatments Being Tested
A single dose study to assess the pharmacokinetics (PK) of oxycodone, when ...
Status
Completed
Location
Quotient Sciences
Start Date
2021-12-01
Trial ID
NCT05090280
Treatments Being Tested
To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formu...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02059915